Bronchiectasis Global Clinical Trials Review, H2, 2018

GlobalData's clinical trial report, “Bronchiectasis Global Clinical Trials Review, H2, 2018" provides an overview of Bronchiectasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bronchiectasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Bayer AG

Aradigm Corp

AstraZeneca Plc

Polyphor AG

Gilead Sciences Inc

Novartis AG

Zambon Company SpA

Savara Inc

Pharmaxis Ltd

Guangzhou Baiyunshan Pharmaceutical General Factory

Bayer AG

Aradigm Corp

AstraZeneca Plc

Polyphor AG

Gilead Sciences Inc

Novartis AG

Zambon Company SpA

Savara Inc

Pharmaxis Ltd

Guangzhou Baiyunshan Pharmaceutical General Factory

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region ...

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by G7 Countries: Proportion of Bronchiectasis to Respiratory Clinical Trials 16

Clinical Trials by Phase in G7 Countries 17

Clinical Trials in G7 Countries by Trial Status 18

Clinical Trials by E7 Countries: Proportion of Bronchiectasis to Respiratory Clinical Trials 20

Clinical Trials by Phase in E7 Countries 21

Clinical Trials in E7 Countries by Trial Status 22

Clinical Trials by Phase 23

In Progress Trials by Phase 24

Clinical Trials by Trial Status 25

Clinical Trials by End Point Status 27

Subjects Recruited Over a Period of Time 28

Clinical Trials by Sponsor Type 29

Prominent Sponsors 30

Top Companies Participating in Bronchiectasis Therapeutics Clinical Trials 32

Prominent Drugs 34

Clinical Trial Profile Snapshots 35

Appendix 145

Abbreviations 145

Definitions 145

Research Methodology 146

Secondary Research 146

About GlobalData 147

Contact Us 147

Source 148

List of Tables

Bronchiectasis Therapeutics, Global, Clinical Trials by Region, 2018* 7

Bronchiectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Bronchiectasis Therapeutics, Global, ...

Bronchiectasis Therapeutics, Global, Clinical Trials by Region, 2018* 7

Bronchiectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Bronchiectasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Bronchiectasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2018* 11

Bronchiectasis Therapeutics Clinical Trials, Europe, Top Five Countries, 2018* 12

Bronchiectasis Therapeutics Clinical Trials, North America, Top Countries, 2018* 13

Bronchiectasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2018* 14

Bronchiectasis Therapeutics Clinical Trials, Central and South America, Top Countries, 2018* 15

Proportion of Bronchiectasis to Respiratory Clinical Trials, G7 Countries (%), 2018* 16

Bronchiectasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Bronchiectasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Bronchiectasis to Respiratory Clinical Trials, E7 Countries (%), 2018* 20

Bronchiectasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21

Bronchiectasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22

Bronchiectasis Therapeutics, Global, Clinical Trials by Phase, 2018* 23

Bronchiectasis Therapeutics, Global, Clinical Trials In Progress by Phase 2018* 24

Bronchiectasis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25

Bronchiectasis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27

Bronchiectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28

Bronchiectasis Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2018* 29

Bronchiectasis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30

Bronchiectasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32

Bronchiectasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34

List of Figures

Bronchiectasis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Bronchiectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Bronchiectasis Therapeutics, ...

Bronchiectasis Therapeutics, Global, Clinical Trials by Region (%), 2018* 7

Bronchiectasis Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2018* 8

Bronchiectasis Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2018* 10

Bronchiectasis Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2018* 11

Bronchiectasis Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2018* 12

Bronchiectasis Therapeutics Clinical Trials, North America, Top Countries (%), 2018* 13

Bronchiectasis Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2018* 14

Bronchiectasis Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2018* 15

Proportion of Bronchiectasis to Respiratory Clinical Trials, G7 Countries (%), 2018* 16

Bronchiectasis Therapeutics, G7 Countries, Clinical Trials by Phase, 2018* 17

Bronchiectasis Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2018* 18

Proportion of Bronchiectasis to Respiratory Clinical Trials, E7 Countries (%), 2018* 20

Bronchiectasis Therapeutics, E7 Countries, Clinical Trials by Phase, 2018* 21

Bronchiectasis Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2018* 22

Bronchiectasis Therapeutics, Global, Clinical Trials by Phase (%), 2018* 23

Bronchiectasis Therapeutics, Global, Clinical Trials In Progress by Phase, 2018* 24

Bronchiectasis Therapeutics, Global, Clinical Trials by Trial Status, 2018* 25

Bronchiectasis Therapeutics Clinical Trials, Global, by End Point Status, 2018* 27

Bronchiectasis Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2013-2017 28

Bronchiectasis Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2018* 29

Bronchiectasis Therapeutics Clinical Trials, Global, Key Sponsors, 2018* 30

Bronchiectasis Therapeutics Clinical Trials, Global, Top Companies by Phase, 2018* 32

Bronchiectasis Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2018* 34

GlobalData Methodology 146

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports